- Home
- TRUE vs FATE Comparison
TRUE vs FATE Comparison
Compare TRUE & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- FATE
- Stock Information
- Founded
- TRUE 2005
- FATE 2007
- Country
- TRUE United States
- FATE United States
- Employees
- TRUE N/A
- FATE N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRUE Technology
- FATE Health Care
- Exchange
- TRUE Nasdaq
- FATE Nasdaq
- Market Cap
- TRUE 114.6M
- FATE 133.0M
- IPO Year
- TRUE 2014
- FATE 2013
- Fundamental
- Price
- TRUE $1.45
- FATE $1.21
- Analyst Decision
- TRUE Buy
- FATE Hold
- Analyst Count
- TRUE 5
- FATE 8
- Target Price
- TRUE $3.19
- FATE $4.14
- AVG Volume (30 Days)
- TRUE 397.0K
- FATE 1.8M
- Earning Date
- TRUE 05-05-2025
- FATE 05-13-2025
- Dividend Yield
- TRUE N/A
- FATE N/A
- EPS Growth
- TRUE N/A
- FATE N/A
- EPS
- TRUE N/A
- FATE N/A
- Revenue
- TRUE $179,356,000.00
- FATE $13,335,000.00
- Revenue This Year
- TRUE $7.54
- FATE N/A
- Revenue Next Year
- TRUE $11.02
- FATE N/A
- P/E Ratio
- TRUE N/A
- FATE N/A
- Revenue Growth
- TRUE 10.18
- FATE 105.85
- 52 Week Low
- TRUE $1.05
- FATE $0.66
- 52 Week High
- TRUE $4.62
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- TRUE 44.81
- FATE 53.44
- Support Level
- TRUE $1.46
- FATE $1.12
- Resistance Level
- TRUE $1.65
- FATE $1.38
- Average True Range (ATR)
- TRUE 0.12
- FATE 0.12
- MACD
- TRUE 0.00
- FATE 0.01
- Stochastic Oscillator
- TRUE 14.71
- FATE 62.22
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.